throbber
THE JOURNAL OF BIOLOGICAL CHEMISIRV VOL 287. NO. 2, pp. 1381 —I 396, January 6, ZDI 2
`0 2m 2 ty The American Society for Biochemistry and Molecular Biology, Inc. Published in the USA
`
`Elucidation of Acid-induced Unfolding and Aggregation of
`Human lmmunoglobulin |gG1 and lgGZ FcIEI
`Received for publication, August 25, 201 1, and in revised form, November 1, 201 1 Published,JBC Papers in Press, November 14, 201 1, DOI 10.1074/ij1 1 1297697
`
`Ramil F. Latypov“, Sabine Hogan’, Hollis Lau*, Himanshu Gadgil“, and Dingjiang Liu§2
`From *Drug Product Development, Amgen Inc., Seattle, Washington 981 79 and §Drug Product Development, Amgen Inc.,
`Thousand Oaks, California 91320
`
`Background: Monoclonal antibodies and PC fusion proteins contain an IgG Fc moiety, which is associated with various
`degradation processes, including aggregation.
`Results: Fc unfolding is triggered by the protonation of acidic residues and depends on the IgG subclass and CH2 domain
`glycosylation.
`Conclusion: Fc aggregation in acidic conditions is determined by CH2 stability.
`Significance: Understanding PC aggregation is important for improving the quality of Fc-based therapeutics.
`
`
`
`no:'9:KmuomusKqfiJO'O‘ll'MMWFdflllwas
`
`Popwlumoa
`
`rently approved therapeutic mAbs belong to the IgG class and
`have a structure schematically depicted in Fig. 1. Intact mAbs
`are composed of two identical light chains and two identical
`heavy chains, which are covalently linked via several inter- and
`intrachain disulfide bonds. The light chains and heavy chains
`form two (VL and CL) and four structurally homologous
`domains (VH, CH1, CH2, and CH3), respectively. The overall
`IgG structure consists oftwo identical Fab domains (VL, CL, VH,
`and CH1) and one PC3 domain (CH2 and CH3) that are con—
`nected by a flexible hinge region. The Fc portion harbors one
`conserved Asn-297 glycosylation site in each of its CH2
`domains. The Fab and PC regions of mAbs have different bio-
`logical functions. The Fab regions are responsible for binding to
`the antigen, whereas the Fc portion plays a role in modulating
`immune cell activity. In addition to mAbs, there are other
`classes of biotherapeutics, such as Fc fusion proteins, that also
`contain Fc. These molecules are composed of therapeutically
`active peptide or protein moieties that are attached to either the
`C termini or N termini of an IgG PC. In such cases, the presence
`of an IgG Fc moiety may result in improved physiological func—
`tion, ease of production, solubility, etc. However, the Fc region
`is also associated with a range of degradation processes, includ—
`ing oxidation (7) and aggregation (8). A detailed understanding
`of how certain structural changes within the Fc domain lead to
`aggregation represents an important step toward improving the
`quality of these therapeutic agents.
`Fc-based biologics offer significant manufacturing and phys—
`iological advantages. Their purification process is greatly sim—
`plified by the available selection of affinity resins targeting the
`Fc portion (9, 10). The presence of a relatively large (~50 kDa)
`and highly soluble Fc moiety confers increased solubility and
`half—life (11). In addition, the Fc region engages in specific bio-
`logically relevant interactions that may require CH2 glycosyla-
`tion (antibody—dependent, cell-mediated cytotoxicity; comple-
`ment activation; in viva clearance; etc.) (12—15). Uncovering
`
`Understanding the underlying mechanisms of Fc aggregation
`is an important prerequisite for developing stable and effica—
`cious antibody-based therapeutics. In our study, high resolution
`two—dimensional nuclear magnetic resonance (NMR) was
`employed to probe structural changes in the IgGl PC. A series of
`lH-‘SN heteronuclear single-quantum correlation NMR spectra
`were collected between pH 2.5 and 4.7 to assess whether unfold—
`ing of CH2 domains precedes that of CH3 domains. The same pH
`range was subsequently screened in PC aggregation experiments
`that utilized molecules of IgGl and IgG2 subclasses with varying
`levels of CH2 glycosylation. In addition, differential scanning
`calorimetry data were collected over a pH range of 3—7 to assess
`changes in CH2 and CH3 thermostability. As a result, compelling
`evidence was gathered that emphasizes the importance of CH2
`stability in determining the rate and extent of PC aggregation. In
`particular, we found that PC domains of the IgG! subclass have a
`lower propensity to aggregate compared with those of the lgGZ
`subclass. Our data for glycosylated, partially deglycosylated, and
`fully deglycosylated molecules further revealed the criticality of
`CH2 glycans in modulating Fc aggregation. These findings pro—
`vide important insights into the stability of Fc-based therapeu—
`tics and promote better understanding of their acid-induced
`aggregation process.
`
`In order to ensure the safety and efficacy of biotherapeutics.
`it is critical to understand and prevent protein degradation. The
`presence of aggregates in therapeutic proteins may jeopardize
`their safety and efficacy by eliciting unwanted immunogenic
`responses (1, 2). Mitigation of aggregation processes while
`maximizing biotherapeutic shelf—life remains one of the out-
`standing challenges in biotechnology.
`Monoclonal antibodies (mAbs) continue to represent the
`leading group of biopharmaceutical products (3— 6). All cur—
`
`El‘lhis article contains supplemental Figs. 51—55.
`‘To whom correspondence should be addressed: Drug Product Develop-
`ment, Amgen Inc, 1201 Amgen Ct. W., Seattle, WA 98119.Tel.: 206—265—
`8851; E—mail: rlatypov@amgen.com.
`2 Present address: Formulation Development, Regeneron Pharmaceuticals,
`Tarrytown, NY 10591.
`
`3The abbreviations used are: Fc, fragment crystallizable; CEX, cation-ex-
`change HPLC; DSC, differential scanning calorimetry; Fab, fragment anti—
`gen-binding; rCE-SDS, capillary electrophoresis under reducing/denatur-
`ing conditions; PNGase F. peptide-.N—glycosidase F; HSQC, heteronuclear
`singlequantum correlation.
`
`JANUARY 6, 2012-VOLUME 287-NUMBER 2 m
`
`JOURNAL OF BIOLOGICAL CHEMISTRY 1 381
`
`CSL EXHIBIT 1081
`
`Page 1 of 17
`
`CSL EXHIBIT 1081
`CSL v. Shire
`
`

`

`Popvolumoa
`
`The Escherichia colt—derived IgGl Fc. CHO-derived IgGl Fc,
`CHO—derived IgG2 PC, and the uniformly 2H,‘5N-labeled,
`E. coli-derived IgGl Fc were supplied by the Protein Sciences
`group at Amgen, Inc. Intact mAbs (IgGl—A, IgGl-B, IgG2-B,
`and IgGZ—C) were supplied by the Process Development group
`at Amgen, Inc. All purified proteins were verified greater than
`95% pure by SDSvPAGE and size exclusion HPLC. Other
`reagents and chemicals were of analytical grade or better. All
`solutions were filtered through a 0.22—um filter prior to use.
`Protein Preparation, Identification, and Characterization—
`The E. coli— and CHO—derived Fc were supplied in 10 mM
`sodium acetate with 9% (w/v) sucrose at pH 5.2. The purity and
`identity of the Fc were verified by reversed—phase HPLC and mass
`spectrometry (see supplemental Figs. 81—53 for details). The
`E. colt—derived IgGl Fc material was the most homogeneous. It
`contained only one minor impurity, a species presumably with an
`unpaired disulfide. The CHO—derived IgGl Fc contained fully gly—
`cosylated species of expected mass and three minor species: 1) a
`sineg oxidized species, 2) a species with an unpaired disulfide, and
`3) a partially glycosylated species. The CHO—derived IgG2 PC was
`more heterogeneous, containing some clips and host cell proteins.
`Its major fraction was composed of two fully glycosylated species
`that presumably differed in sulfation.
`The lgGl—B-derived Fc fragments with differing levels of
`CH2 glycosylation were prepared as follows. Two milliliters of
`IgGl—B at 6 mg/ml were incubated with 24 pl 0f PNGase F
`(New England Biolabs, Ipswich, MA) in 1 X G7 buffer for 45 min
`at 37 °C. Endoproteinase Lys-C (Roche Applied Science) was
`then added to the reaction mixture at a protein/enzyme weight
`ratio of 200:1. The sample was incubated at 37 °C for an addi—
`tional 15 min before quenching with 150 mM ammonium ace—
`
`FIGURE 1. Schematic diagram of an lgG molecule. As indicated by the
`dashed line, an lgG structure consists of one Fc and two identical Fab regions.
`Thin blue lines represent intra- and interchain disulfide bonds. The structure
`of a carbohydrate unit attached to Asn-297 of the CH2 domain is shown sep-
`arately. LC, light chain; HC, heavy chain; 6, galactose; GN, N—acetylglucos—
`amine; F, fucose; M, mannose.
`
`the various sources of Fc instability that are connected with
`particular CH2 glycoforms will enable production of biologics
`with enhanced pharmacological properties.
`In a typical purification process, mAbs and PC fusion proteins
`are exposed to acidic conditions during viral inactivation and
`elution from affinity resins (9, 16). It is well known that low pH
`conditions may result in protein denaturation and aggregation
`(17, 18). It was shown that acidic pH and high ionic strength can
`promote formation of nonnative protein structures. Some of
`the best
`studied, partially folded, acid—denatured states
`(A—states or molten globule states) are populated at low pH in
`the presence of salt. For example, an acid molten globule state
`of cytochrome c is formed at pH 2.0 —2.5 in the presence of
`0.5—1.5 M salt (19 —21). Apomyoglobin, filactamase, and staph—
`ylococcal nuclease also exhibit an acid— and salt—induced forma—
`tion of A-states at low pH (22—25). Monoclonal antibodies and
`their fragments are no exceptions to this rule. Buchner and
`co—workers (26 —28) demonstrated that
`intact mAbs, Fab
`regions, and even isolated CH3 domains form A—states at acidic
`pH and high ionic strength. Although the stability and structure
`of these states are highly dependent on the protein and experi—
`mental conditions, their common characteristic is a tendency
`to aggregate (17, 29, 30). Unlike small, single—domain proteins.
`mAbs are complex glycoproteins composed of several inde-
`pendently folded domains. Commercial mAb preparations are
`rather heterogeneous and may contain differentially processed,
`
`1 382 JOURNAL OF BIOLOGICAL CHEMISTRY
`
`m VOLUME 287- NUMBER 2 -JANUARY 6, 2012
`
`Fc Aggregation in Acidic Conditions Is Determined by CH2 Stability
`
`LC
`
`F |
`
`. — GN — GN — M /\ M — GN — G
`
`M — GN — G
`
`incompletely glycosylated, and covalently modified forms (31).
`The understanding of mAb aggregation is challenged by the
`intrinsic and extrinsic complexity (not to mention the storage
`history) of antibody preparations.
`Despite the aforementioned issues, significant progress has
`been made in understanding and preventing aggregation in bio—
`pharmaceuticals (for a recent review, see Ref. 32). It was recog—
`nized that lgG aggregation can be induced by various factors
`and proceed through different mechanisms (33—36); however,
`the role of individual antibody domains in aggregation
`remained poorly understood. Recently, we proposed that acid-
`induced aggregation of mAbs is controlled by the stability of
`CH2 domains located in the Fc region (8). At the time, no struc—
`tural evidence was generated concerning the extent of CH2
`unfolding associated with this aggregation process. We are now
`filling this gap by gathering all of the necessary structural and
`stability data to implicate the CH2 domain. The scope of our
`study was limited to Fc fragments to allow for the use of high
`resolution two—dimensional NMR and to reduce the number of
`
`differential seaming calorimetry (DSC) transitions. In addi—
`tion, various forms of PC (Le. with respect to IgG subclass and
`degree of CH2 glycosylation) were analyzed under conditions
`promoting acid—induced aggregation. As a result, we revealed
`the aggregation rank order of the most typical lgG Fc domains
`currently used in biotechnology.
`
`EXPERIMENTAL PROCEDURES
`
`
`
`no:'9:KmuowensKqfilO'O‘iF/M‘Wfldnllwas
`
`Page 2 of 17
`
`

`

`S\l
`
`protein relative to an appropriate control stored refrigerated in
`10 mM sodium acetate, pH 5.2. Unstable proteins exhibited a
`faster decrease in the CEX monomer concentration compared
`with more stable proteins (8, 35).
`Cation—exchange Chromatography—Aggregation of mAb
`and PC mixtures was investigated by cation—exchange chroma—
`tography at pH 5.2 (35, 37). The method was run on an Agilent
`1100 series HPLC system. Chromatography was performed on
`a ProPac WCX—IO analytical column (weak cation exchange.
`4 X 250 mm; Dionex. Sunnyvale, CA) preceded by a ProPac
`WCX—IOG guard column (weak cation exchange, 4 X 50 mm;
`Dionex) at 25 "C. Protein samples were loaded onto the column
`and analyzed at a flow rate of 0.7 ml/min. The column was
`equilibrated with Buffer A (20 mM sodium acetate, pH 5.2), and
`protein was eluted with a linear gradient of Buffer B (20 mM
`sodium acetate, 300 mM sodium chloride, pH 5.2) from 0 to
`100% over 35 min. Following elution, the column was washed
`with Buffer C (20 mM sodium acetate, 1 M sodium chloride, pH
`5.2) for 5 min and then re—equilibrated with Buffer A for 16 min.
`Absorbance was measured at 215, 235, and 280 mm. Data were
`analyzed with Dionex Chromeleon® software, and the 280 nm
`signal was integrated to determine protein peak area.
`Difi‘erential Scanning Calorimetry—DSC measurements
`were taken using a VP-Capillary DSC system (MicroCal Inc.,
`Northampton, MA) equipped with tantalum 61 cells, each with
`an active volume of 135 p,l. Protein samples, typically at 0.5
`mg/ml, were scanned from 20 to 110 °C at a rate of 60 °C/h
`following an initial 15-min equilibration at 20 “C. A filtering
`period of 16 s was used, and the data were analyzed using Origin
`7.0 software (OriginLab® Corp., Northampton, MA). Resulting
`thermograms were corrected by subtraction of buffer control
`
`.5?9.
`
`Q 3o
`
`;2o3 Z
`
`9s
`
`a8G
`
`- 8 '
`
`8”33"
`:1
`p
`
`‘2N
`«LIIN
`
`Fc Aggregation in Acidic Conditions Is Determined by CH2 Stability
`
`tate at pH 4.7 (37). The sample was then cooled and maintained
`at 4 °C for immediate purification or frozen at —80 °C to arrest
`further enzyme activity.
`Glycosylated, partially deglycosylated, and fully deglycosy-
`lated Fc were purified using the CEX method described below
`(also see Ref 37). Digested IgGl-B material was loaded onto the
`column in multiple injections. An Agilent 1200 series HPLC
`system with a 12/ 13 SelValve external valve (Agilent Technol-
`ogies, Santa Clara, CA) was used to perform the fractionation.
`Resulting fractions containing the same species were pooled
`and concentrated and then reanalyzed by CEX. Purity greater
`than 90% was achieved for all
`three Fc species based on
`reversed-phase HPLC and mass spectrometry (see supplemen—
`tal Fig. S4).
`Aggregation Experiments—Previously, we demonstrated that
`CEX can be used to measure the aggregation propensity of both
`intact and fragmented mAbs (8, 35). This same method was
`applied in the current study, where mAb and Fc mixtures were
`exposed to different solution conditions. In our experiments,
`each protein was at 0.5 mg/ml final concentration unless noted
`otherwise. mAb and Fc mixtures were prepared in a native
`buffer composed of 10 mM sodium acetate at pH 5.2. They were
`subsequently diluted into various solutions of interest and incu—
`bated quiescently at 30 °C for up to several days. Sample ali—
`quots were taken at predetermined intervals and analyzed
`immediately or stored on ice to reduce further aggregation. The
`loss of soluble monomer was determined for each individual
`
`scans. The corrected thermograms were normalized for protein
`concentration.
`
`NuclearMagnetic Resonance—PC NMR measurements were
`performed at 25 °C using a Varian [NOVA 800—MHz NMR
`spectrometer (Varian Inc., Palo Alto, CA) equipped with a
`5—mm triple resonance probe. The uniformly 2H,15N—labeled
`E. coli-derived IgGl PC was tested at 5 mg/ml in 10 mM sodium
`acetate adjusted by HCl to pH 2.5, 3.1, 3.5, and 4.7.
`lH-ISN HSQC spectra were acquired with 64 experiments
`run in the 15N dimension (t1) consisting of 16 scans and 1024
`data points in the 1H dimension (£2). The total experimental
`time for each spectral acquisition was 37 min. Spectra were
`processed using NMRPipe (38) and analyzed using NMRView
`(39). The lH-‘sN cross—peak assignments from Liu et al. (40)
`were used. The weighted average chemical shift difference was
`calculated as described previously (41).
`Reversed-phase Chromatography and Mass Spectrometry—
`Reversed—phase analysis of the E. coli—derived IgGl Fc, CHO-
`derived IgGl PC, and CHO-derived IgG2 PC was carried out on
`a Waters (Milford, MA) Acquity system, equipped with a
`Diphenyl 3 pm, 1 X 50—mm column (Varian Inc.) as described
`previously (42). Typically, 5 pg of protein was injected on the
`column. The column was held at 95% solvent A (0.1% TFA in
`water) and 5% solvent B (90% acetonitrile and 0.085% TFA in
`water) for 5 min followed by a gradient from 5% B to 38% B over
`13 min. Fc elution was achieved with a linear gradient from 38%
`B to 46% B in 40 min at a flow rate of 0.05 ml/min. The column
`
`temperature was maintained at 75 °C throughout the run, and
`detection was at 214 nm.
`
`Reversed—phase analysis of the IgGl—B—derived PC was car—
`ried out on a Waters Acquity UPLC system as previously
`described (42). Typically, 5 ug of sample was injected onto an
`Acquity BEH 1.7 pm 1 X 50 mm phenyl column. The column
`was held at 72% solvent A (0.1% TFA in water) and 28% solvent
`B (90% acetonitrile and 0.085% TFA in water) for 0.7 min. $01—
`vent B was increased to 31.4% at 0.9 min, to 49.4% at 3.4 min,
`and to 90% at 3.5 min. At 4.10 min, solvent B returned to the
`
`starting level (28%) and remained constant until the end of the
`assay at 5 min. The column temperature was maintained at
`80 r‘C throughout the run, the flow rate was kept constant at
`0.35 ml/ min, and the detection was at 214 nm.
`
`The mass spectrometric analysis was carried out in positive
`ion mode on a Waters Q—TOF Premier or LCT Premier mass
`spectrometer equipped with an electrospray ionization source.
`The capillary and cone voltages were set at 3200 and 60 V,
`respectively. The desolvation and source temperatures were set
`at 350 and 80 "C, respectively. All other voltages were optimized
`to provide maximal signal intensity. The instrument was cali—
`brated in the m/z range of 1500—4000 using multiply charged
`ions of a standard antibody with a calculated molecular mass
`value of 148.2512 Da or commercial trypsinogen with a mass of
`32,300 Da. All raw data were processed using Waters MassLynx
`MaxEnt 1 software to obtain the deconvoluted mass.
`
`RESULTS
`
`Effect of Acidic Conditions on IgGJ Fc Structure via NMR
`Analysis—Although PC is a relatively large protein (~50 kDa),
`recent studies demonstrated that it is amenable to high resolu-
`
`JANUARY 6, 2012-VOLUME 287-NUMBER 2
`
`m
`
`JOURNAL OF BIOLOGICAL CHEMISTRY 1 383
`
`Page 3 of 17
`
`

`

`S\l
`
`tion two—dimensional NMR analysis (7, 43). Furthermore, res—
`onance assignments from Liu et al. (40) made investigation of
`pH effects on IgGl Fc structure straightforward. In the current
`study, the Fc conformation was assessed between pH 2.5 and
`4.7 by acquiring a series of ‘H—lsN HSQC spectra of the uni—
`formly 2H,15N—labeled E. coli—derived IgGl Fc. Due to the low
`ionic strength of the protein solutions (see “Experimental Pro—
`cedures"), no evidence of aggregation was seen in any of the Fc
`samples throughout the experiment. At pH 4.7, the amide
`peaks of Fc were highly dispersed, which was consistent with a
`folded conformation (see Fig. 2A). A similar degree of disper—
`sion was seen at pH 3.5, although a number of peaks were
`reduced in intensity (Fig. 28). In addition, some new, low inten—
`sity peaks emerged that were not present at higher pH. At pH
`3.1, a subset of native resonances disappeared, whereas a differ—
`ent set of peaks appeared (Fig. 2C). Spectral properties of these
`new peaks were characteristic of a disordered, largely unfolded
`protein conformation. They resembled the minor resonances
`that were barely visible at pH 3.5. The remaining native reso-
`nances disappeared at pH 2.5, where NMR showed limited peak
`dispersion, consistent with an unfolded state (Fig. 2D).
`At pH 3.5 and 4.7, the number of assigned amide resonances
`available for analysis was 116 and 117, respectively. This repre-
`sented 51% of the 227 PC amino acid residues. Many of the
`missing peaks originated from the vicinity ofthe hinge region or
`
`9S
`
`a8n
`
`. 3:
`
`p 3:
`
`r
`:1
`"F!
`
`g;9.
`
`Q S"
`
`.2
`2o:1
`§‘<
`"n
`
`nf
`
`Fc Aggregation in Acidic Conditions Is Determined by CH2 Stability
`
`
`
`
`
`15NChemicalShift(ppm)
`
`1H Chemical Shift (ppm)
`FIGURE 2. 1H-“N HSQC spectra of the uniformly 2H.15N-labeled E. coli-derived lgGl F: at pH 4.7 (A), 3.5 (B), 3.1 (C), and 2.5 (D). The spectra were
`recorded at 25 °C.
`
`were due to peak overlap between the different pH spectra. The
`number of native resonances dropped to 46 at pH 3.1, and none
`were present at pH 2.5.
`shift
`residue—specific, chemical
`The weighted average,
`changes between pH 3.5 and 4.7 and between 3.1 and 3.5 are
`shown in Fig. 3. The most prominent changes between pH 3.5
`and 4.7 were clustered around residue positions 250—255 and
`310 —315 (Fig. 3A). These regions overlap with two short CH2
`a—helices that interface with the CH3 domains (see “Discus—
`sion”). In addition, notable chemical shift changes (20.05 ppm)
`were associated with positions corresponding to Asp—280, Gln—
`295, Leu—306, and Thr—335 of CH2 and Gly—385 and Lys—447 of
`CH3. Similar regions produced peaks with reduced intensity at
`pH 3.5, which probably reflected changes in the CH2 conforma—
`tional dynamics. Moreover, some of the native resonances that
`were present at pH 4.7 apparently disappeared at pH 3.5, among
`them resonances from Lys—290 and possibly Trp—277 and Val—
`412 (see Table 1).
`Peaks indicating the presence of a folded CH2 domain were
`virtually non—existent at pH 3.1, suggesting that major unfold-
`ing had occurred (Fig. 2C). Therefore, estimates for the chem—
`ical shift changes between pH 3.1 and 3.5 were only available for
`CH3 domains (Fig. 3B). At least three residue positions showed
`significant chemical shift changes at pH 3.1: Arg-34-4, Trp-381,
`and Lys-447. Of interest is the Arg-34-4 residue, the residue near
`
`1384 JOURNAL OF BIOLOGICAL CHEM/577W
`
`m VOLUME 287-NUMBER 2-JANUARY 6, 2012
`
`Page 4 of 17
`
`

`

`conditions to induce Fc aggregation within a short period of
`time at moderately elevated temperatures. First, we performed
`a pH screening experiment using protein solutions buffered
`with 10 mM sodium acetate to mimic the conditions that were
`
`LIOZ‘szKewuoIssnflKqfilo'oqi'mmwrduuwoe
`
`
`
`340
`Residue Number
`
`
`300
`
`.0 _.
`
` WeightedAverageChemicalsnmcnange(ppm)
`
`used for NMR. The samples contained a mixture of four differ—
`ent molecules: three full—length mAbs (IgGl—A, IgGZ—B, and
`IgG2—C) and E. colt—derived IgG] Fc. The choice to use the
`three mAbs was dictated by our previous experience with these
`molecules (8, 35). They served as internal controls to optimize
`solvent composition and incubation time to assess Fc aggrega—
`tion. In agreement with the NMR results, aggregation was not
`observed in these low ionic strength solutions at pH 3—5 even
`after 2 days of storage at 30 °C (data not shown). This was con—
`sistent with the important role of the ionic strength and acid
`concentration in low pH mAb aggregation (8). Subsequently,
`the pH screening was repeated in the presence of high (100 mM)
`sodium acetate with and without 50 mM NaCl (the correspond—
`ing solutions are abbreviated as 100Ax and 100AxN, where A
`represents sodium acetate, x is the pH, and N is NaCl). All four
`molecules were premixed in 10 mM sodium acetate at pH 5.2
`prior to being exposed to the low pH conditions. Fig. 4, A and B,
`shows CEX chromatographic traces for samples incubated in
`100A37N and 100A34, respectively. Fig. 5 summarizes results
`from various conditions in terms of percentage of monomer
`recovery based on CEX. It is evident that IgGl—A aggregated
`only at pH 3.4 (Fig. 5, A and E), whereas aggregation of Fc and
`the two lgGZs occurred at pH 3.7— 4.1 (Fig. 5, B and F, C and G,
`andD and H. respectively). Previously, we observed that low pH
`aggregation of mAbs was dependent on CH2 glycosylation
`and the IgG subclass (8). In particular, glycosylated IgGl
`mAbs were more resistant to aggregation compared with
`their glycosylated IgG2 counterparts, whereas an aglyco—
`IgGl (an IgGl mAb devoid of CH2 glycosylation) was the
`least stable molecule tested (8). Consistent with these find—
`ings, Fig. 5 reveals the following aggregation rank order of
`the four molecules (listed from the highest aggregation pro—
`pensity to the lowest): E. colt—derived IgGl Fc (Le. aglyco—
`IgG] PC) > IgGZ-C > IgG2—B > IgGl—A. Aggregation pro—
`pensity of Fc in 100A34 and 100A34N was particularly high
`and resulted in the loss of 30 — 40% of monomer at t = 0 (Fig.
`5, D and H, respectively). Thus, the CEX data demonstrated
`an increased instability of aglyco—IgGl Fc compared with
`glycosylated mAbs. Furthermore, the aggregation rank order
`for these molecules was the same in either the 100Ax or
`
`meow/ma
`
`Fc Aggregation in Acidic Conditions Is Determined by CH2 Stability
`
`pH 3.5—4.7
`
`
`
`
`
`
`
`
`
`220
`
`260
`
`300
`
`340
`Residue Number
`
`380
`
`420
`
`FIGURE 3. The weighted average chemical shift changes of the uniformly
`2H,1 sN-labeled E. coIi-derived IgG1 Fe. The graphs show residue-specific
`perturbations induced by a pH reduction from 4.7 to 3.5 (A) and from 3.5 to 3.1
`(B). The location of the hinge region as well as the CH2/CH3 domains is indi-
`cated in B. Residue numbering is listed in Eu format (44).
`
`the loop connecting the CH2 and CH3 domains. Changes at this
`position are probably the result of structural changes in the
`adjacent CH2 domain. This is supported by the simultaneous
`disappearance of many of the CH3 resonances originating from
`positions 366 —380 and 428 —438 (Table 1). Both of these seg—
`ments contain residues forming the CHZ—CH3 domain inter—
`face. which probably gets disrupted because of CH2 unfolding
`(see "Discussion").
`A further reduction in pH from 3.1 to 2.5 resulted in the
`disappearance of all remaining folded resonances (Fig. 2D). The
`NMR spectrum of PC at pH 2.5 was now consistent with an
`unfolded protein conformation devoid of stable tertiary or sec—
`ondary structure. The high affinity CH3—CH3 interaction was
`probably disrupted also, as demonstrated by the lack of native
`resonances originating from the domain contact area. Specifi—
`cally, this was reflected by the absence of native amide peaks
`from the following residues: Leu-351, Glu—357, Ser—364. Leu—
`368, Lys—370, Thr—394, Asp—399, Phe—405, and Lys—409. Because
`all of these positions were in a native-like environment at higher
`pH, the data were consistent with a scenario where dissociation
`and unfolding of the CH3—CH3 interchain complex occurred
`simultaneously (see "Discussion”).
`CEX Analysis of PC Aggregation—Previously, we demon—
`strated the utility of CEX in measuring the aggregation propen—
`sity of both intact and fragmented mAbs (8, 35). Similar to size
`exclusion HPLC, CEX is a nondenaturing chromatographic
`technique that can effectively separate aggregates from mono—
`mers. However, in contrast to size exclusion HPLC, CEX can
`
`resolve complex mixtures composed of similarly sized proteins.
`Working with protein mixtures allows us to monitor the aggre—
`gation of different molecules simultaneously and under identi—
`cal conditions. Hence, CEX was selected to establish the rank
`order of Fc aggregation as a function of CH2 glycosylation and
`subclass (IgGl versus IgG2).
`In addition to separating aggregates from monomers, CEX is
`useful in detecting degraded or chemically modified proteins
`(31, 37). This was an added benefit because our goal was to
`measure Fc aggregation with minimal interference from chem—
`ical degradations. Our initial studies were focused on finding
`
`IOOAxN conditions, which indicated the following: 1) the
`underlying aggregation mechanism was largely unaffected
`by NaCl, and 2) the rate and extent of Fc aggregation could
`be appropriately modulated by varying the ionic strength.
`Because covalent modification and fragmentation were not
`evident in these experiments (see Fig. 4), protein aggregation
`was the major degradation process. In summary, sufficient
`evidence was gathered to support the low pH approach for
`generating Fc aggregation data.
`Our next experiment was performed on a mixture composed
`of three different Fc moieties: E. colt—derived IgGl Fc, CHO—
`derived IgGl Fc, and CHO—derived IgGZ PC. This mixture was
`subjected to aggregation in the 100A31N and 100A35N condi—
`tions as outlined above. The CEX overlays corresponding to
`
`JANUARY 6, 2012-VOLUME 287- NUMBER 2
`
`me
`
`JOURNAL OF BIOLOGICM CHEM/SEW 1 385
`
`Page 5 of 17
`
`

`

`Fc Aggregation in Acidic Conditions ls Determined by CH2 Stability
`
`TABLE 1
`
`Fc residues that lost their natlve amlde resonances upon pH reductlon (relatlve to the 1H-‘SN HSQC spectrum acqulred at pH 4.7 (Fig. 2A))
`pH
`Hinge
`CH2
`CH3“
`3.5
`3.1
`
`Tilt-223
`
`Trp—277", Lys—290
`Val’240, Phe-243, Lys—248, Asp-249, Thr-ZSO, Leu’
`251, Met—252, SET—254. Arg—255, Glu—258, Tin—260,
`Cys—26l, Val—263, Lys—274. Asn—276, Trp—277", Tyr—
`278, Val-279, Asp-280, Gly-281, Val-282, Glu-283,
`Lys-290, Glu-294, Ser—298, Arg-301.Val-303. Ser—
`304. Leu—306, Thr—307, Val—308, His—310, Gin—311,
`Asp-312, Trp—313, Asn»315, Gly»316, Lys»317, Tyr-
`319, Lys—320, Val—323, Ala-330, Thr-335, Ile-336,
`Ser—337, Ala—339
`All
`All
`2.5
`An"
`“ Disappearance of native CH3 resonances at pH 3.5 and 3.1 may not necessarily reflect structural changes in CH3. it may also result from peak overlap with resonances origi-
`nating from denatured CH2.
`1’ Disappearance of the native resonance from this residue is uncertain because of peak overlap.
`‘ This residue resides between CH2 and CH3 domains.
`“ Because native resonance assignments for the hinge residues were incomplete (see “Experimental Procedures"), implications of CH2/CH3 denaturation on the hinge confor—
`mation are not fully understood.
`
`meow/ma
`
`Val»412"
`Gly-Mlc, Glu-345, Gln-34-7, Thr-366, Val-
`369, Gly—37l, Set—375, Asp—376, Ile—377,
`Ala—378, Glu—380, Gln—386, Tyr—391. Val—
`397, Tyr-407, Val—412b, Gln-418, Met-428,
`HisA29, Ala431, LeuAB2, His»433, Tyr-
`436, Gln—438
`
`no:‘szKewuoIssnflKqfilo'oqi'MMW/iduuwoe
`
`nature of the Fc samples, the CHO—derived IgGl Fc (including
`all minor forms) was evidently more resistant to aggregation
`compared with its aglycosylated (E. coli) variant or the CH0—
`derived IgG2 Fc. Aggregation of the latter two molecules
`appeared similar in 100A35N but differed in 100A31N. In par—
`ticular, aglyco—IgGl Fc lost ~55% of monomer at t = 0 but
`aggregated more slowly afterward (gray symbols in Fig. 6C). The
`initial monomer loss of the CHO—derived IgG2 PC was less than
`40%, but the remaining monomer disappeared rapidly (open
`symbols in Fig. 6C). Because all three molecules were premixed
`at pH 5.2 prior to the low pH exposure, this result indicated a
`lack of stability of the aglyco—IgGl and glyco—IgG2 Fc. Conse—
`quently, the rank order of PC aggregation was found to be as
`follows: aglyco—IgGl Fe 2 IgG2 Fc (CHO) > IgGl Fc (Cl-[0).
`This was consistent with our earlier findings (8) as well as the
`aggregation rank order that was drawn from Fig. 5. Therefore, a
`conclusion was made that the 100A31N and 100A35N condi—
`
`tions primarily promoted a CH2—dependent aggregation
`mechanism.
`
`Our last aggregation experiment utilized differentially glyco—
`sylated Fc fractions generated from another IgGl mAb, IgGl—B.
`The success of this experiment depended on 1) the ability of
`CEX to resolve Fc fragments with different levels of CH2 glyco—
`sylation and 2) the optimization of PNGase F treatment to
`achieve an optimal ratio of glycosylated, partially deglycosy—
`lated, and fully deglycosylated PC for purification. The ability of
`CEX to separate differentially glycosylated PC was verified by
`analyzing PNGase F—treated and -untreated IgGl-B following
`Lys—C limited proteolysis (data not shown). Subsequently,
`IgGl—B and PNGase P concentrations were varied along with
`incubation temperature and duration to achieve an optimal
`rate of digestion and desired ratio of glycosylated, partially
`deglycosylated, and fully deglycosylated Fc. Storage temper—
`ature and duration after digestion were also assessed to
`ensure that this ratio was sufficiently maintained over the
`course of purification (see "Experimental Procedures"). The
`resulting Fc fractions were verified by reversed—phase HPLC
`and mass spectrometry (see supplemental Fig. S4), mixed
`together, and subjected to an aggregation process in
`100A31N. The corresponding CEX results are shown in Fig.
`7, A and B. In agreement with the data in Fig. 6C, glycosy—
`lated PC was more resistant to aggregation compared with its
`
`A 7°
`60
`
`50
`
`4o
`
`30
`20
`
`
`
`UVAbs(280nm)
`
`lgG2-B
`
`IgGZ—C
`
`E. coli lgG1 Fc
`
`Aggregates
`
`18 2124 27
`
`30
`
`33
`
`36
`
`Elution time, min
`
`E. coli lgG1 Fc
`
`Aggregates
`
`CD
`
`
`
`uvAbs(280nm)
`
`
`
`18
`
`21
`
`24
`
`27
`
`30
`
`33
`
`36
`
`l—I—I—I
`41

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket